According to the manufacturer’s instructions, small interfering RNA (si-p62: F: GUCUCCGAUAUCUGUUAAUTT, R: AUUAACAGAUAUCGGAGACTT; si-Usp5: F: GGAGUUCUUCCUUCACCUUTT, R: AAGGUGAAGGAAGAACUCCTT; si-Wt1: F: AAAUUGUCACUGCUGUGUAGGTT, R: CCUACACAGCAGUGACAAUUUTT) was transfected into KGN cells using Lipofectamine 3000 Transfection Kit (Invitrogen, CN2481208) [72 (link)]. All siRNA and negative control siRNA were purchased from GenaPharma (Suzhou, China).
Unless otherwise specified, FSH (National Hormone and Peptide Program, USA; 10 µg/µL) was added to cell culture for 48 h, and other specific drug concentrations were shown as follows. CQ (17,589 A; 10 µM), MG132 (13,259; 10 µM), PR-619 (13,814; 10 µM), USP5-IN-1 (139,979; 7.5 µM) and CHX (12,320; 10 µM) were both purchased from MedChemExpress.